ArticleJournal of osteoporosis2015

Denosumab for Elderly Men with Osteoporosis: A Cost-Effectiveness Analysis from the US Payer Perspective.

Stuart Silverman et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.